[go: up one dir, main page]

AU3494397A - Fibroblast growth factor receptor activating gene i and related compositions and methods - Google Patents

Fibroblast growth factor receptor activating gene i and related compositions and methods

Info

Publication number
AU3494397A
AU3494397A AU34943/97A AU3494397A AU3494397A AU 3494397 A AU3494397 A AU 3494397A AU 34943/97 A AU34943/97 A AU 34943/97A AU 3494397 A AU3494397 A AU 3494397A AU 3494397 A AU3494397 A AU 3494397A
Authority
AU
Australia
Prior art keywords
methods
growth factor
factor receptor
fibroblast growth
related compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34943/97A
Inventor
Matthew V. Lorenzi
Toru Miki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
United States, Represented By Secretary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States, Represented By Secretary filed Critical United States, Represented By Secretary
Publication of AU3494397A publication Critical patent/AU3494397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU34943/97A 1996-06-18 1997-06-18 Fibroblast growth factor receptor activating gene i and related compositions and methods Abandoned AU3494397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2000996P 1996-06-18 1996-06-18
US60020009 1996-06-18
PCT/US1997/010660 WO1997048813A2 (en) 1996-06-18 1997-06-18 Fibroblast growth factor receptor activating gene 1 (frag1). fgfr2-frag1 fusions

Publications (1)

Publication Number Publication Date
AU3494397A true AU3494397A (en) 1998-01-07

Family

ID=21796262

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34943/97A Abandoned AU3494397A (en) 1996-06-18 1997-06-18 Fibroblast growth factor receptor activating gene i and related compositions and methods

Country Status (3)

Country Link
US (4) US6323316B1 (en)
AU (1) AU3494397A (en)
WO (1) WO1997048813A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3494397A (en) 1996-06-18 1998-01-07 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Fibroblast growth factor receptor activating gene i and related compositions and methods
US6451572B1 (en) 1998-06-25 2002-09-17 Cornell Research Foundation, Inc. Overexpression of phytase genes in yeast systems
AU2002356880A1 (en) 2001-10-31 2003-05-12 Phytex, Llc Phytase-containing animal food and method
EP2083081A1 (en) 2005-07-22 2009-07-29 Five Prime Therapeutics, Inc. Compositions and methods of treating disease with FGFR fusion proteins
US20070144800A1 (en) * 2005-11-30 2007-06-28 Stone Kevin T System and method for braking resistor supplemental heating
HUE039085T2 (en) * 2006-01-20 2018-12-28 Cell Signaling Technology Inc Translocation and mutant ROS kinase in human non-small cell lung carcinoma
EP2046384A4 (en) * 2006-06-15 2009-12-02 Fibron Ltd Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof
WO2008017066A2 (en) 2006-08-03 2008-02-07 Cornell Research Foundation, Inc. Phytases with improved thermal stability
BRPI0916904A2 (en) 2008-08-04 2016-10-11 Fiveprime Therapeutics Inc polypeptides, ecd fgfr4 fusion molecules, pharmaceutical compositions, polynucleotide and methods of treating angiogenic disorder, patient cancer and patient macular degeneration and their uses
LT3290052T (en) 2008-11-07 2020-02-25 Galaxy Biotech, Llc Monoclonal antibodies to fibroblast growth factor receptor 2
PL2498799T3 (en) 2009-11-13 2017-03-31 Five Prime Therapeutics, Inc. Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
EP2512501A4 (en) 2009-12-17 2014-01-01 Five Prime Therapeutics Inc Hair growth methods using fgfr3 extracellular domains
US8481038B2 (en) 2010-11-15 2013-07-09 Five Prime Therapeutics, Inc. Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
CA2855818A1 (en) 2011-11-14 2013-05-23 Five Prime Therapeutics, Inc. A method of treating lung cancer having an fgfr1 gene amplification or fgfr1 overexpression
NZ715201A (en) 2013-08-01 2021-12-24 Five Prime Therapeutics Inc Afucosylated anti-fgfr2iiib antibodies
EP3380523A1 (en) 2015-11-23 2018-10-03 Five Prime Therapeutics, Inc. Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatment
EP4650004A2 (en) 2017-05-16 2025-11-19 Five Prime Therapeutics, Inc. Anti-fgfr2 antibodies in combination with chemotherapy agents in cancer treatment
CN108949768B (en) * 2018-04-28 2021-09-07 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） A RAB22A-NoeFs fusion gene line for diagnosing and/or treating osteosarcoma and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE131175T1 (en) 1990-04-27 1995-12-15 Takeda Chemical Industries Ltd PROTEIN WITH FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY.
DE69304331T2 (en) 1992-06-18 1997-01-16 The Whittier Institute For Diabetes And Endocrinology, La Jolla, Calif. METHOD FOR DETECTING NEOPLASTIC DISEASES
AU3494397A (en) 1996-06-18 1998-01-07 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Fibroblast growth factor receptor activating gene i and related compositions and methods

Also Published As

Publication number Publication date
US6323316B1 (en) 2001-11-27
US7297493B2 (en) 2007-11-20
US20020032310A1 (en) 2002-03-14
WO1997048813A2 (en) 1997-12-24
US6608181B2 (en) 2003-08-19
US20030212260A1 (en) 2003-11-13
WO1997048813A3 (en) 1998-02-12
US20050153325A1 (en) 2005-07-14
US6831170B2 (en) 2004-12-14

Similar Documents

Publication Publication Date Title
AU3494397A (en) Fibroblast growth factor receptor activating gene i and related compositions and methods
AU9692198A (en) Gene delivery compositions and methods
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU7714898A (en) Bone morphogenetic proteins and their use in bone growth
AU6298894A (en) Compositions and methods for promoting hair growth
AU2741597A (en) Flowerpot and associated attachments
AU3011497A (en) Novel human growth factors
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU2358397A (en) Implement hand support and control
AU2664797A (en) Wnt receptor compositions and methods
AU2653095A (en) Fibroblast growth factor-14
AU1903799A (en) Compositions and methods for modulating the activity of fibroblast growth factor
AU3170499A (en) Fibroblast growth factor mutein compositions and methods of use therefor
AU2653195A (en) Fibroblast growth factor 11
AU2408397A (en) Ob protein receptor genes and use of the same
AU3200197A (en) New composition and methods
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU4551597A (en) Controlled gene expression in plants
AU2697995A (en) Fibroblast growth factor 13
AU7359496A (en) Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
AU5914299A (en) Antagonists of fibroblast growth factor
AU9393798A (en) Genetic compositions and methods
AU3480197A (en) Method and compositions for controlling gene expression
AU1350699A (en) Compositions and methods for modulating the activity of fibroblast growth factor
AU3510197A (en) Growth arrest gene compositions and methods